IL22 and metabolic dysfunction-associated steatotic liver disease: Similarly, interleukin-22 (IL-22)-expressing Lactobacillus reuteri obviously decreased the incidence of nonalcoholic fatty liver disease in high-fat diet mice (Oh et al., 2020).